Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders: 1118 (Advances in Experimental Medicine and Biology, 1118) - Image 1

£105.19

Springer Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders: 1118 (Advances in Experimental Medicine and Biology, 1118)

Name: Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders: 1118 (Advances in Experimental Medicine and Biology, 1118)
Brand: Springer
Price: 107.32 GBP
Availability: InStock

Biochemistry

Price History & Forecast

Last 34 days • 34 data points (No recent data available)

Historical

Generating forecast...

Price Distribution

Price distribution over 34 days • 2 price levels

Days at Price

Current Price

Price Analysis

Most common price: £107 (23 days, 67.6%)

Price range: £105 - £107

Price levels: 2 different prices over 34 days

Description

Product Description This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome. From the Back Cover This book includes a series of reviews on general aspects of biomarker use in the study of psychiatric and neurodegenerative diseases and the development of medications involved in their treatment. It describes the pros and cons of the various approaches and covers the successes and failures in this research field. It is only by a thorough understanding of the shortcomings that progress can be made. The overall goal is to facilitate the understanding and treatment of these disorders, by providing a viable mechanism of catching up with other areas of modern medicine, such as diabetes and heart disease. Finally, it is anticipated that the development and application of valid biomarker tests and the leveraging of novel drug targets will help the fields of psychiatry on neurodegenerative disorders move into the area of personalized medicine where the right patients can receive the right medication at the right time for the best possible outcome. About the Author Dr Paul C. Guest, Ph.D, is a scientific researcher/writer with 35 years of experience in the fields of metabolic and neurological disorders. This includes experience in both academia and the pharmaceutical industry with the majority of time spent at the University of Cambridge and Merck Sharp & Dohme in the United Kingdom. He has also been affiliated with the University of Campinas in Sao Paulo Brazil since 2015, still focused on advancing the field of biomarkers for neurological disorders such as schizophrenia and Alzheimer’s disease.

Product Specifications

Brand: Springer
Format: Hardcover
ASIN: 3030055418
Category: Books > Subjects > Science, Nature & Maths > Biological Sciences > Biochemistry
Domain: Amazon UK
Release Date: 21 February 2019
Listed Since: 07 November 2018

Barcode

No barcode data available

Springer Reviews on Biomarker Studies in Psychiatric and Neurodegenerative Disorders: 1118 (Advances in Experimental Medicine and Biology, 1118)

Price History & Forecast

Price Distribution

Price Analysis

Description

Product Specifications

Barcode

Similar Products You Might Like

Springer Reviews on Biomarker Studies of Metabolic Disorders 1134

Reviews on New Drug Targets in Age-Related Disorders: 1260 (Advances in Experimental Medicine and Biology, 1260)

The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume III: Metabolic and Peripheral Biomarkers: 03

Biomarkers for Psychiatric Disorders

Neurodegenerative Diseases: Clinical Aspects, Molecular Genetics and Biomarkers

Identification of Biomarkers, New Treatments, and Vaccines for COVID-19: 1327 (Advances in Experimental Medicine and Biology, 1327)

The Handbook of Neuropsychiatric Biomarkers, Endophenotypes and Genes: Volume IV: Molecular Genetic and Genomic Markers: 04

Advances in Medicine and Medical Research: 1133 (Advances in Experimental Medicine and Biology, 1133)

Advances in Medicine and Medical Research: 1133 (Advances in Experimental Medicine and Biology, 1133)

Psychopharmacology of Neurologic Disease: Handbook of Clinical Neurology Series (Volume 165)

Springer Proteomic Methods in Neuropsychiatric Research 974

Staging Neuropsychiatric Disorders: Implications for Etiopathogenesis and Treatment

Biomarkers of Cardiometabolic Risk, Inflammation and Disease

Neurodegenerative Disorders as Systemic Diseases

Neuroepigenomics in Aging and Disease: 978 (Advances in Experimental Medicine and Biology, 978)

Global Emergency of Mental Disorders

Multiparametric Imaging in Neurodegenerative Disease (Neuroscience Research Progress)

The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders

The Burden of Adult ADHD in Comorbid Psychiatric and Neurological Disorders

Springer Proteomic Methods in Neuropsychiatric Research 974

Neurodegenerative Diseases: Pathology, Mechanisms, and Potential Therapeutic Targets: 15 (Advances in Neurobiology, 15)

Neurophenotypes: Advancing Psychiatry and Neuropsychology in the "OMICS" Era (Innovations in Cognitive Neuroscience)

Neurophenotypes: Advancing Psychiatry and Neuropsychology in the "OMICS" Era (Innovations in Cognitive Neuroscience)

Biomarkers for Traumatic Brain Injury: Volume 24 (Drug Discovery Series)